CIBC Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

CIBC Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,927	Closed	-$281K	–	1317
2022 Q2	$281K	Sell	3,927 -284	-7%	-$20.8K	﹤0.01%	919
2022 Q1	$341K	Hold	4,211	–	–	﹤0.01%	987
2021 Q4	$432K	Sell	4,211 -5	-0.1%	-$480	﹤0.01%	887
2021 Q3	$369K	Buy	4,216 +330	+8%	+$29.9K	﹤0.01%	923
2021 Q2	$348K	Hold	3,886	–	–	﹤0.01%	924
2021 Q1	$295K	Sell	3,886 -63	-2%	-$4.75K	﹤0.01%	973
2020 Q4	$269K	Hold	3,949	–	–	﹤0.01%	960
2020 Q3	$210K	Buy	3,949 +98	+3%	+$5.83K	﹤0.01%	987
2020 Q2	$224K	Buy	+3,851	New	+$207K	﹤0.01%	921
2020 Q1	–	Sell	-3,851	Closed	-$229K	–	1173
2019 Q4	$229K	Buy	+3,851	New	+$207K	﹤0.01%	999

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC Asset Management's SYNH Position: Q3 2022 in Review

CIBC Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 3,927 shares — an estimated $281K sold.

CIBC Asset Management first reported a position in SYNH in Q4 2019 and held it in 10 quarters. The position peaked at $432K in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

CIBC Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
CIBC Asset Management sold 3,927 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $281K.
CIBC Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 10 quarters.
CIBC Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $432K in Q4 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on CIBC Asset Management's 13F filing for Q3 2022, filed 3 Nov 2022.